<rss version="2.0"><channel><title>BioSpace.com News</title><link>http://www.biospace.com</link><generator>BioSpace RSS Generator</generator><lastBuildDate>Wed, 19 Jun 2013 00:15:44 GMT</lastBuildDate><ttl>20</ttl><image><url>http://rss.biospace.com/images/BSPLogo.gif</url><title>BioSpace.com</title><link>http://www.BioSpace.com/news.aspx?SectionId=1</link></image><copyright>Copyright (C) 2011</copyright><item><title>&lt;b&gt;BoXin LaiTe Biotechnology&lt;/b&gt; and University of British Columbia Sign MOU  </title><link>http://www.chinabiotoday.com/articles/20130618</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;by Richard Daverman, PhD&lt;br&gt;&lt;br&gt;June 18, 2013 -- Sichuan BoXin LaiTe Biotechnology and its major shareholder, Heracles International Investment Inc. have signed a memorandum of understanding to form a partnership...</description><pubDate>Tue, 18 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>AstraZeneca PLC and NGM Biopharmaceuticals, Inc. Form Diabetes/Obesity Partnership  </title><link>http://www.biospace.com/news_story.aspx?StoryID=300116&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;AstraZeneca: MedImmune, AstraZenecas Biologics Arm, and NGM Biopharmaceuticals Announce Agreement to Discover and Develop Therapies for Diabetes and Obesity&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;SDERTLJE...</description><pubDate>Mon, 17 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Summit Corporation Achieves Clinical Milestone Triggering ??740,000 Payment From Wellcome Trust to Fund Novel C. Difficile Antibiotic  </title><link>http://www.biospace.com/news_story.aspx?StoryID=300176&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Oxford, UK, 17 June 2013 - Summit (AIM: SUMM), a drug discovery and development company advancing therapies for Duchenne Muscular Dystrophy and C. difficile infections ('CDI'), announces that it has achieved...</description><pubDate>Mon, 17 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Genmab A/S and Enter Co-Development Collaboration for an Antibody-Drug Conjugate Combining HuMax-TAC and PBD Warhead  </title><link>http://www.globenewswire.com/news-release/2013/06/17/554294/0/en/Genmab-and-ADC-Therapeutics-Enter-Co-Development-Collaboration-for-an-Antibody-Drug-Conjugate-Combining-HuMax-TAC-and-PBD-Warhead.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Copenhagen, Denmark and Lausanne, Switzerland; June 17, 2013  Genmab A/S (OMX: GEN) and ADC Therapeutics Sarl announced today an agreement to develop a new antibody-drug conjugate (ADC) product combining Genmab...</description><pubDate>Mon, 17 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Bristol-Myers Squibb Company, Simcere Pharmaceutical Group Form Pact for Development of RA Treatment  </title><link>http://www.chinabiotoday.com/articles/20130614</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia SC (abatacept) in China&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;PRINCETON, N.J. &amp; NANJING, China--(BUSINESS WIRE...</description><pubDate>Fri, 14 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Codexis, Inc. and Achieve Key Milestone in Commercial Development of Bio-Based Chemicals From Non-Food Cellulosic Biomass  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130614005423&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;REDWOOD CITY, Calif. &amp; TORTONA, Italy--(BUSINESS WIRE)--Codexis (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, and Chemtex, a leader in chemical engineering...</description><pubDate>Thu, 13 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>NeuroVive Pharmaceutical AB Signs $7.6 Million JV With  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299762&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;NeuroVive Pharmaceutical: NeuroVive signs collaboration agreement with Isomerase Therapeutics and receives the first milestone payment from Sihuan&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;STOCKHOLM--(BUSINESS...</description><pubDate>Wed, 12 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Zealand Pharma  Enters Collaboration With D. E. Shaw Research With the Objective of Adding a New Dimension to Peptide Drug Design  </title><link>http://www.globenewswire.com/news-release/2013/06/12/553589/0/en/Zealand-enters-collaboration-with-D-E-Shaw-Research-with-the-objective-of-adding-a-new-dimension-to-peptide-drug-design.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Copenhagen, 2013-06-12 14:00 CEST (GLOBE NEWSWIRE) -- - The collaboration will combine D. E. Shaw Researchs state-of-the-art computational capabilities with Zealands broad-based discovery and development competencies...</description><pubDate>Wed, 12 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Proteome Sciences PLC to Develop Cancer Pathway Profiling Assays  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299807&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;12 June, 2013 - Proteome Sciences today announced its largest contract to date, a technology agreement with Thermo Fisher Scientific, valued at $2.1million by Proteome Sciences, to develop advanced methods to...</description><pubDate>Wed, 12 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Promega Corporation and Sign Exclusive Distribution Agreement for and Northern Ireland  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299812&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Madison, WI, USA. (12 June, 2013) Promega Corporation announced today that it has selected MyBio, Irelands leading specialist bioscience reagents supplier, to be its new, exclusive distributor in the Republic...</description><pubDate>Wed, 12 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Abcam plc Signs License Agreement With Pfizer Inc. to Supply Compounds to Researchers  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299813&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Cambridge UK, 12 June 2013: Abcam Plc., a producer and distributor of high quality protein research tools, announced today that it has entered into a license agreement with Pfizer. Under the terms of the agreement...</description><pubDate>Wed, 12 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>BioAmber Inc. and Sign European Distribution Agreement for Resins &amp; Coatings  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299863&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;MINNEAPOLIS, MN and ROTTERDAM, Netherlands, June 12, 2013  /PRNewswire/ - BioAmber Inc. (NYSE and EURONEXT Paris: BIOA) and IMCD Group announced today that IMCD is now distributing BioAmber's biobased succinic...</description><pubDate>Wed, 12 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>TTP LabTech Ltd. Supports Rapidly Growing Cognitive Drug Discovery Efforts at Dart NeuroScience LLC  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299722&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;June 11, 2013 -- TTP Labtech, global developer and manufacturer of innovative, high quality, automated laboratory equipment, has signed an agreement with Dart NeuroScience, LLC (DNS), a specialised pharmaceutical...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Imaxio&lt;/b&gt; Signs an Option for a License Agreement With a Leading Global Animal Health Company to Develop Veterinary Vaccines  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299665&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Lyon, France, June 10, 2013 - Imaxio, a biopharmaceutical company specialized in vaccines and genomics, announces today that it has signed a license option agreement with a major animal health laboratory, a...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Cobra Biologics Ltd. and Unveil Successful Development of Bacteriophages Against Bacterial Infection  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299611&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;11 June 2013: Cobra Biologics Ltd, the International clinical and commercial manufacturer of biologics and pharmaceuticals and Novolytics, a biotechnology company developing anti-infective products, today announce...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Recipharm AB Provides Access to Asmasal Clickhaler Dossier for Vectura Group plc Chinese Market Approval  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299614&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;11 June 2013 -- Recipharm AB is pleased to announce that it is working with Vectura Group plc to provide access to its licence for the regulatory dossier of Asmasal for the Chinese regulatory authorities as...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Alacris Theranostics GmbH&lt;/b&gt; Announces Illumina, Inc. CSPro Certification for Next Generation Sequencing  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299692&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Berlin, Germany, June 11, 2013 - Alacris Theranostics GmbH announced today that it has successfully completed Illumina CSPro(TM) certification for next generation sequencing (NGS); gaining entry to an elite...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Tianjin SinoBiotech Ltd.&lt;/b&gt; &amp; &lt;b&gt;Beijing Bio-Fortune Ltd.&lt;/b&gt; Announce a U.S. Market Licensing Agreement for Their Intellectual Property on the Treatment of Neutropenia With One of the Global Top 10 Pharmaceutical Companies  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130611005081&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;BEIJING--(BUSINESS WIRE)--Prof. Zailin Yu, Yan Fu with Tianjin SinoBiotech Ltd. &amp; Beijing Bio-Fortune Ltd. (the Licensor), privately held biotechnology and biopharmaceutical companies, announced today that...</description><pubDate>Tue, 11 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>BioLineRx Ltd. Signs a $30 Million Hepatitis Deal With a Leading Chinese Company  </title><link>http://www.chinabiotoday.com/articles/20130610</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;BioLineRx Enters into Collaboration to Develop and Commercialize Hepatitis C Drug with CTTQ, Leading Chinese Pharma Company for Liver Disease Therapeutics&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;JERUSALEM-...</description><pubDate>Mon, 10 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Elekta-Partnership to Increase South African Cancer Patients??? Access to Radiation Therapy  </title><link>http://www.globenewswire.com/news-release/2013/06/10/552884/0/en/Elekta-Equra-Health-Partnership-to-Increase-South-African-Cancer-Patients-Access-to-Radiation-Therapy.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;CAPE TOWN and STOCKHOLM, June 10  To address the growing need for radiationtherapy services in South Africa, Equra Health (Cape Town) has entered into along-term agreement with Elekta in which Equra will...</description><pubDate>Mon, 10 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;ExpreS2ion Biotechnologies&lt;/b&gt; and the Protein Purification Facility at Cancer Research UK's London Research Institute Enter a Licensing Agreement for Use of the ExpreS2 Technology Platform  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299488&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Hrsholm, Denmark, and London, UK, 10th June, 2013 / B3C newswire /  Biotech company ExpreS2ion Biotechnologies today announced that they have signed a research license agreement to provide the Protein Purification...</description><pubDate>Mon, 10 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>China's and Columbia University Join to Form Pathogen Lab in Beijing  </title><link>http://www.chinabiotoday.com/articles/20130607</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;by Richard Daverman, PhD&lt;br&gt;&lt;br&gt;June 5, 2013 -- Chinas Center for Disease Control and Prevention will team up with The Center for Infection and Immunity (CII) of Columbia University to form the Joint Research...</description><pubDate>Mon, 10 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Exiqon A/S and Asuragen, Inc. Sign Agreement for Real-Time PCR Services  </title><link>http://www.globenewswire.com/news-release/2013/06/10/552945/0/en/Exiqon-and-Asuragen-sign-agreement-for-real-time-PCR-services.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value products for gene expression analysis, and Asuragen, Inc. a fully integrated molecular diagnostics company focused on oncology and companion diagnostics...</description><pubDate>Mon, 10 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Zydus Cadila Seeks Big Pharma Tie-Up to Launch Diabetes Drug Overseas  </title><link>http://www.moneycontrol.com/news/business/zydus-cadila-seeks-tie-up-to-launch-diabetes-drug-overseas_891346.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Zydus Cadila today said it is looking for partnership to market its new chemical entity (NCE) Lipaglyn, to be used for treating a type of diabetes in developed and developing markets. "Lipaglyn is the first...</description><pubDate>Thu, 06 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Isis Pharmaceuticals, Inc. Receives $10 Million Milestone Payment  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299218&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;CARLSBAD, Calif.&lt;/span&gt;, &lt;span class"xn-chron"&gt;June 6, 2013&lt;/span&gt; /PRNewswire/ -- Isis Pharmaceuticals...</description><pubDate>Thu, 06 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Trinean nv Signs a Global Agreement With Bayer CropScience AG  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299278&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;GENTBRUGGE, Belgium, June 6, 2013  Trinean, the leading provider of microfluidic spectrophotometry platforms, today announced it has entered into a long-term agreement with Bayer CropScience to supply DropSense...</description><pubDate>Thu, 06 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Flamel Technologies Announces Product Partnership Agreement  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299328&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;LYON, FRANCE--(Marketwired - June      06, 2013) -   Flamel Technologies (NASDAQ: &lt;a href"http://www.marketwire.com/mw/stock.jsp?TickerFLML"&gt;FLML&lt;/a&gt;) today announced a multi-year...</description><pubDate>Thu, 06 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Curie-Cancer&lt;/b&gt; and &lt;b&gt;Biolog-id&lt;/b&gt; Sign Partnership Agreement to Develop a Traceability System for Cancer Chemotherapy Preparations  </title><link /><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Paris and Bernay, France, June 4, 2013 - Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activity and Biolog-id, a French SME which develops, manufactures and markets...</description><pubDate>Thu, 06 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;London BioScience Innovation Center&lt;/b&gt; Welcomes &lt;b&gt;HistoIndex&lt;/b&gt; as 50th Client  </title><link>http://www.biospace.com/news_story.aspx?StoryID=299259&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;London, UK, 06 June 2013  The London BioScience Innovation Centre (LBIC), Londons premier incubator for life science companies, has signed Singapore-based medical imaging company HistoIndex as its 50th registered...</description><pubDate>Thu, 06 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Meda AB Expands Collaboration With the Indian Pharmaceutical Company Cipla Ltd.  </title><link>http://www.globenewswire.com/news-release/2013/06/05/552185/0/en/Meda-expands-collaboration-with-the-Indian-pharmaceutical-company-Cipla.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Meda is broadening its collaboration with the Indian pharmaceutical companyCipla, thereby expanding its exclusive rights to Dymista and future productdevelopment. Through the extended partnership, Meda now...</description><pubDate>Wed, 05 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Genor Biopharma&lt;/b&gt; and &lt;b&gt;BioCND&lt;/b&gt; to Co-Develop Two Popular Biosimilars  </title><link>http://www.chinabiotoday.com/articles/20130603</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;by Richard Daverman, PhD&lt;br&gt;&lt;br&gt;June 3, 2013 -- Genor Biopharma of Shanghai has agreed with BioCND, a Korean biosimilar CRO and consulting firm, to co-develop biosimilars of two popular monoclonal...</description><pubDate>Tue, 04 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Vectura Group plc Potential Royalty and Milestone Payments on Fibrocaps&amp;#0153;  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298947&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Chippenham, UK  4th June 2013: Vectura Group plc (Vectura or the Company; LSE: VEC), announces that the Company could receive a 2m change of control payment as part of the potential acquisition announced...</description><pubDate>Tue, 04 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Dr. Reddy's Laboratories Ltd., FUJIFILM Holdings Corporation Call Off Generic Drug JV  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298675&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;Fujifilm and Dr. Reddy's Call Off Joint Venture for Generic Drugs in Japan&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;HYDERABAD, India--(BUSINESS WIRE)-- FUJIFILM Corporation ("Fujifilm" hereinafter) and Dr. Reddy...</description><pubDate>Mon, 03 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Tesaro, Inc.,  and the European Organization for Research and Treatment of Cancer Announce Collaboration for Niraparib Clinical Development in Breast Cancer  </title><link>http://www.globenewswire.com/news-release/2013/06/03/551479/10034914/en/TESARO-Breast-International-Group-BIG-and-the-European-Organization-for-Research-and-Treatment-of-Cancer-EORTC-Announce-Collaboration-for-Niraparib-Clinical-Development-in-Breast-C.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;CHICAGO and BRUSSELS, Belgium, June 3, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO), an oncology-focused biopharmaceutical company, Breast International Group (BIG), a non-profit organization for academic...</description><pubDate>Mon, 03 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>Enamine Ltd. Provides With Large Novel Diverse Screening Compound Library  </title><link /><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;KIEV, Ukraine &amp; BASEL, Switzerland--(BUSINESS WIRE)--Enamine Ltd, a leading provider of screening compounds, chemical building blocks and discovery services, and Exquiron Biotech AG, a company specializing in...</description><pubDate>Mon, 03 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>EffRx Signs Distribution Agreement With Ahn-Gook Pharmaceuticals for Binosto&amp;#0174; for Korea  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130603006214&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;FREIENBACH, Switzerland--(BUSINESS WIRE)--EffRx Pharmaceuticals S.A. today announces the signing of an exclusive distribution agreement with Ahn-Gook Pharmaceutical Co. Ltd for Binosto - EffRxs innovative...</description><pubDate>Mon, 03 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;S.Fyodorov Eye Microsurgery Complex&lt;/b&gt; and &lt;b&gt;NovaMedica&lt;/b&gt; Have Signed a Cooperation Agreement on Localizing Innovative Ophthalmic Treatment Technologies in Russia  </title><link>http://www.businesswire.com/portal/site/biospace/template.PAGE/menuitem.ab520ce17e34ab71ff00d635c0908a0c/index.jsp?ndmViewId=news_view&amp;newsId=20130603005429&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;MOSCOW--(BUSINESS WIRE)--S.Fyodorov Eye Microsurgery Complex Federal State Institution and NovaMedica (a pharmaceutical subsidiary of RUSNANO and Domain Associates) have signed an agreement that covers cooperation...</description><pubDate>Mon, 03 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Inflection Biosciences&lt;/b&gt; Licenses Preclinical Oncology Programs From the &lt;b&gt;Spanish National Cancer Research Centre&lt;/b&gt;  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298752&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Dublin, Ireland: June 3, 2013  Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule treatments for cancer, today announced that it has entered into a license agreement...</description><pubDate>Mon, 03 Jun 2013 12:00:00 AM GMT</pubDate></item><item><title>BeiGene Co.,Ltd Licenses Ex-China Rights for Cancer Molecule to Merck Serono  </title><link>http://www.chinabiotoday.com/articles/20130601</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;by Richard Daverman, PhD&lt;/p&gt;&lt;p&gt;May 31, 2013 -- BeiGene, a Beijing biopharma startup, has out-licensed the ex-China rights for a pre-clinical cancer drug to Merck Serono, the drug discovery arm of Germany...</description><pubDate>Fri, 31 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Evogene Ltd. to Collaborate With Chinese Biotechnology Company on Improving Key Rice Traits  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298469&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;REHOVOT, ISRAEL and BEIJING--(Marketwired - May       29, 2013) -  &lt;table class"releaseLink"&gt;&lt;tr&gt;&lt;td class"releaseLink"&gt;&lt;b&gt;Highlighted Links&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;a href...</description><pubDate>Thu, 30 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Amgen Ties With Astellas Pharma Inc. to Tackle Japan  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298131&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;Amgen And Astellas Announce Japan Alliance&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;THOUSAND OAKS&lt;/span&gt;, Calif. and &lt;span class"xn-location"&gt;TOKYO&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 29, 2013&lt;/span&gt; /PRNewswire...</description><pubDate>Wed, 29 May 2013 12:00:00 AM GMT</pubDate></item><item><title>5 Japanese Big Pharmas Ban Together to Form $100 Million R&amp;D Pact  </title><link>http://www.ft.com/intl/cms/s/0/f49398f6-c5ed-11e2-99d1-00144feab7de.html#axzz2UgtYfTHT</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Five of Japans largest pharmaceutical companies have joined forces with their government in a pioneering $100m partnership to fund international research into treatments for diseases of the poor. The Global...</description><pubDate>Wed, 29 May 2013 12:00:00 AM GMT</pubDate></item><item><title>QIAGEN Inc. and Announce Translational Medicine JV  </title><link>http://www.chinabiotoday.com/articles/20130528_1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;by Richard Daverman, PhD&lt;/p&gt;&lt;p&gt;May 28, 2013 -- Qiagen, a Dutch molecular diagnostics company that provides sample and assay technologies, will set up a translational medicine R&amp;D JV with Suzhous BioBay...</description><pubDate>Wed, 29 May 2013 12:00:00 AM GMT</pubDate></item><item><title>A*STAR  and Collaborate to Develop Low Cost Interposer Technology  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298215&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;May 29, 2013 -- 1.   Singapore 29 May, 2013-- Singapores A*STAR Institute of Microelectronics (IME), Qualcomm Technologies Inc., a wholly owned subsidiary of Qualcomm Incorporated, and STATS ChipPAC have announced...</description><pubDate>Wed, 29 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Genome Institute of Singapore and Enter Into Partnership for Early Detection of Cancer Cells  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298263&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;29 May 2013 -- The Genome Institute of Singapore (GIS) of the Agency for Science, Technology and Research (A*STAR), and Sengenics today announced a partnership for cancer biomarker discovery with the aim to...</description><pubDate>Wed, 29 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;FuturaGene&lt;/b&gt; Enters Agreement With &lt;b&gt;Danforth Center&lt;/b&gt; to Provide Plant Yield-Enhancing Technology to Developing Countries  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298265&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Sao Paulo, Brazil  Wednesday, May 29, 2013  FuturaGene, a world leader in the enhancement of yield and sustainability of woody crops for plantation forestry, biopower and biofuel markets, has entered into...</description><pubDate>Wed, 29 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Merck Serono Courting Biotechnology Start-ups  </title><link>http://www.bostonglobe.com/business/2013/05/23/merck-serono-latest-drug-maker-turned-investor-biopharmaceutical-start-ups/h8UiUK4M3zRwaEZn7XHQYO/story.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Stefan Oschmann came courting biotechnology start-ups last week, a trans-Atlantic visitor promising not only pharmaceutical industry expertise but also cash. Oschmann, who made his pitch to several dozen area...</description><pubDate>Tue, 28 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Cobra Biologics Ltd. and Recopharma AB Enter Agreement to Utilise Cell Line Development Service- MaxXpress  </title><link>http://www.biospace.com/news_story.aspx?StoryID=298000&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;28 May 2013 -- Cobra Biologics Ltd, the international clinical and commercial manufacturer of biologics and pharmaceuticals and Recopharma, a biotechnology company developing ophthalmic products, today announce...</description><pubDate>Tue, 28 May 2013 12:00:00 AM GMT</pubDate></item><item><title>NovaBay Pharmaceuticals, Inc. and Virbac Corporation Enter Into a Collaboration and License Agreement for Animal Health  </title><link>http://www.globenewswire.com/news-release/2013/05/28/550012/10034133/en/NovaBay-Pharmaceuticals-and-Virbac-Enter-Into-a-Collaboration-and-License-Agreement-for-Animal-Health.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;EMERYVILLE, Calif. and CARROS, France, May 28, 2013 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc., (NYSE:NBY), a clinical-stage biotechnology company focused on the topical, anti-infective market, today...</description><pubDate>Tue, 28 May 2013 12:00:00 AM GMT</pubDate></item><item><title>miRagen Therapeutics Achieves First Milestone in Strategic Alliance With Servier  </title><link>http://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&amp;newsId=20130523005280&amp;newsLang=en</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;SURESNES, France &amp; BOULDER, Colo.--(BUSINESS WIRE)--Servier, a privately-run French research-based pharmaceutical company and a major player in Europe and emerging markets having expertise in the development...</description><pubDate>Thu, 23 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Flamel Technologies Obtains Rights to Two Molecules of Trigger Lock Product Line  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297845&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;LYON, FRANCE--(Marketwired - May       23, 2013) -   Flamel Technologies (NASDAQ: &lt;a href"http://www.marketwire.com/mw/stock.jsp?TickerFLML"&gt;FLML&lt;/a&gt;) today announced that it has exercised...</description><pubDate>Thu, 23 May 2013 12:00:00 AM GMT</pubDate></item><item><title>GlaxoSmithKline Gets $200 Million US Contract for Antibiotics  </title><link>http://www.washingtontimes.com/news/2013/may/22/us-forges-200-million-antibiotic-deal-glaxosmithkl/?utm_source=RSS_Feed&amp;utm_medium=RSS</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism. The collaboration, the first of its...</description><pubDate>Wed, 22 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Agilent Technologies Inc., University of Rouen and A*STAR's Bioprocessing Technology Institute to Further Innovation in Biopharmaceuticals and Glycomics  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297646&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;May 22, 2013 -- 1.         Agilent Technologies Inc. (NYSE: A), the Glyco-MEV laboratory at the University of Rouen, in France, and the Bioprocessing Technology Institute at the Agency for Science, Technology...</description><pubDate>Wed, 22 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Grifols Signs Deal to License Aradigm Corporation's Pulmaquin for Up to $90.7 Million  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297336&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;font size"3"&gt;&lt;b&gt;Grifols, S.A. and Aradigm Corporation Announce Signing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin&lt;/font&gt;&lt;/b&gt;&lt;br&gt;&lt;br&gt;BARCELONA, Spain &amp; HAYWARD, Calif.--(BUSINESS...</description><pubDate>Tue, 21 May 2013 12:00:00 AM GMT</pubDate></item><item><title>More Details About Pfizer Inc. and Merck &amp; Co., Inc.-Simcere Pharmaceutical Group JVs  </title><link>http://www.chinabiotoday.com/articles/20130521</link><description>by Richard Daverman, PhD&lt;/p&gt;&lt;p&gt;May 21, 2013 -- In 2011, the worlds two largest drugmakers  Pfizer and Merck  each announced major China drug JVs with domestic China pharmas  Hisun in Pfizers case and Simcere for Merck. The arrangements were high-profile, and their aims went beyond drug distributorship, reaching into drug development. But details have been slow to emerge. A recent article in...</description><pubDate>Tue, 21 May 2013 12:00:00 AM GMT</pubDate></item><item><title>DBV Technologies and Stallergenes, S.A. Enter Into Partnership for the Development of Innovative Treatment of Respiratory Allergies  </title><link>http://www.biospace.com/news_story.aspx?StoryID=297159&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;ANTONY, FRANCE and BAGNEUX, FRANCE--(Marketwired - May       16, 2013) -   DBV Technologies(EURONEXT PARIS: DBV) (ISIN: FR0010417345), creator of Viaskin&amp;#174;, a newstandard in...</description><pubDate>Fri, 17 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Biohit to Strengthen its GastroPanel Distribution in China - New Partner  </title><link>http://www.globenewswire.com/news-release/2013/05/16/547741/0/en/Biohit-to-strengthen-its-GastroPanel-distribution-in-China-new-partner-Hefei-Medicine.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Biohit Oyj has signed a distribution agreement with Hefei Medicine to strengthen the sales and marketing of GastroPanel in China. The agreement covers the distribution and marketing of Biohits diagnostic products...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Curie-Cancer&lt;/b&gt; and Roche Strengthen Partnership to Fast-Track the Development of New Molecules  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296946&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;15 May 2013 -- Curie-Cancer, the body responsible for developing Institut Curies industry partnership activities, and the Roche Institute for Research and Translational Medicine are strengthening their collaborative...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Amgen's New JV Fulfills Promise to Emphasize China  </title><link>http://www.chinabiotoday.com/articles/20130515_1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;by Richard Daverman, PhD&lt;/p&gt;&lt;p&gt;May 15, 2013 -- To date, Amgen, the US biotech drug company, has not had a major presence in China. In February of this year, Amgen said it would use a combination of partnerships...</description><pubDate>Thu, 16 May 2013 12:00:00 AM GMT</pubDate></item><item><title>BASF and Dyadic International, Inc. Enter Into a Research and License Agreement  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296699&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;LUDWIGSHAFEN, &lt;span class"xn-location"&gt;Germany&lt;/span&gt; and &lt;span class"xn-location"&gt;JUPITER, Fla.&lt;/span&gt;, &lt;span class"xn-chron"&gt;May 15, 2013&lt;/span&gt; /PRNewswire/ -- BASF (BAS.DE) and Dyadic International, Inc...</description><pubDate>Wed, 15 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Almac Group Secures New Metagenomics and Enzyme Discovery Program With University College London  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296795&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;May 15, 2013 -- The Almac biocatalysis group has secured a prestigious BBSRC (Biotechnology and Biological Sciences Research Council) programme with UCL focused specifically on metagenomics and novel enzyme...</description><pubDate>Wed, 15 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Cempra Pharmaceuticals, Inc., Toyama Chemical Company Ink Up to $70 Million Pact to Produce Anti-Pneumonia Drug  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296466&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;b&gt;Cempra, Inc. Signs Exclusive License and Development Agreement for Solithromycin With Toyama Chemical Co., Ltd., a Subsidiary of FUJIFILM Holdings Corporation in Japan&lt;/b&gt;&lt;br&gt;&lt;br&gt;Read more here: http...</description><pubDate>Tue, 14 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Cobra Biologics Ltd. and Vaccibody  Sign Agreement to Manufacture DNA Vaccine  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296542&amp;full=1</link><description>14th May 2013 -- Cobra Biologics Ltd, the international clinical and commercial manufacturer of biologics and pharmaceuticals and Vaccibody AS, a biotechnology company developing the next generation of vaccines against cancer and chronic infections, today announce an agreement to manufacture Vaccibodys lead DNA vaccine candidate against HPV-induced malignancies, such as precancerous lesions found...</description><pubDate>Tue, 14 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Evotec AG Q1 2013: Driving Innovation Efficiency  </title><link>http://www.globenewswire.com/news-release/2013/05/14/546752/10032696/en/Evotec-Q1-2013-Driving-Innovation-Efficiency.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;HAMBURG, Germany, May 14, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today reported financial results and corporate updates for the first quarter of 2013.&lt;br&gt;&lt;br&gt;Help...</description><pubDate>Tue, 14 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Vectura Group plc, Chinese Partners Form $65 Million Respiratory JV  </title><link>http://www.chinabiotoday.com/articles/20130513</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;b&gt;Vectura Establishes Strategic Partnership (Kinnovata) for New Respiratory Business in China&lt;/b&gt;&lt;br&gt;&lt;br&gt;Chippenham, UK  13 May 2013: Vectura Group plc (LSE: VEC) (Vectura), announces that it has established...</description><pubDate>Mon, 13 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;BioGaia&lt;/b&gt; Signs Exclusive Distribution Agreement in China  </title><link>http://www.globenewswire.com/news-release/2013/05/13/546445/0/en/BioGaia-signs-exclusive-distribution-agreement-in-China.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;BioGaia has signed an agreement with Beijing Keyuan Xinhai Pharmaceutical Co Ltdfor the exclusive rights to sell BioGaias ProTectis baby drops and ProTectisand Gastrus tablets through the retail pharmacy...</description><pubDate>Mon, 13 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Moberg Derma and Paladin Labs Inc. Extends Agreement for Kerasal&amp;#0153; Nail to Mexico  </title><link>http://www.globenewswire.com/news-release/2013/05/13/546368/0/en/MOBERG-PHARMA-AND-PALADIN-EXTENDS-AGREEMENT-FOR-KERASAL-NAIL-TO-MEXICO.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Moberg Pharma AB (OMX: MOB) today announced that Paladin has been granted theexclusive rights to market and sell Kerasal Nail in Mexico. Kerasal Nail is anover-the-counter (OTC), topical product with a...</description><pubDate>Mon, 13 May 2013 12:00:00 AM GMT</pubDate></item><item><title>2012 in Review: Biocitech SAS Focuses on Collaboration With Regional Players  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296433&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Biocitech, May 13, 2013  Biocitech, the life sciences technology park based in Paris, France, today announces its annual review of 2012. Biocitech concluded a variety of agreements with regional players throughout...</description><pubDate>Mon, 13 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Amgen Takes a Stab in China and Forms Pact With  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296197&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;b&gt;Amgen and Zhejiang Beta Pharma Announce Planned Joint Venture in China&lt;/b&gt;&lt;br&gt;&lt;br&gt;THOUSAND OAKS, Calif. and ZHEJIANG, China, May 9, 2013 -- /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Zhejiang Beta Pharma...</description><pubDate>Fri, 10 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Hutchison China MediTech (Chi-Med) in Partner Talks for Cancer Drug  </title><link>http://www.chinabiotoday.com/articles/20130509</link><description>by Richard Daverman, PhD&lt;/p&gt;&lt;p&gt;May 9, 2013 -- Hutchison Chi-Med expects to license global rights to fruqintinib, one of its novel small-cell cancer drugs, before year-end, according to CEO Christian Hogg. The company has been in due diligence discussions with potential partners, he added. Because the drug is a promising treatment for solid tumors, Chi-Med will conduct simultaneous clinical trials...</description><pubDate>Fri, 10 May 2013 12:00:00 AM GMT</pubDate></item><item><title>A*STAR's Genome Institute of Singapore Partners to Discover and Monitor Cells for Pathologies or Abnormalities  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296229&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Singapore, 10th May 2013  The Genome Institute of Singapore (GIS) from the Agency for Science, Technology and Research (A*STAR) and Oxford Biodynamics (OBD) will collaborate to identify epigenetic signatures...</description><pubDate>Fri, 10 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Orgenesis&lt;/b&gt; and ATMI Enter Into Process Development Agreement  </title><link>http://www.globenewswire.com/news-release/2013/05/09/545893/10032164/en/Orgenesis-and-ATMI-Enter-Into-Process-Development-Agreement.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;TEL AVIV, Israel and WHITE PLAINS, N.Y., May 9, 2013 (GLOBE NEWSWIRE) -- Orgenesis Inc. (OTCBB:ORGS) ("Orgenesis" or the "Company"), a development-stage company with a novel therapeutic technology dedicated...</description><pubDate>Thu, 09 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Institute for Infocomm Research (I2r)&lt;/b&gt;, Singapore's Largest ICT Research Institute, Collaborates With Globally Competitive Companies and Invents Impactful Technologies Anchored by Scientific Research  </title><link>http://www.biospace.com/news_story.aspx?StoryID=296099&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Singapore  8 May 2013  The Institute for Infocomm Research (I2R), a research institute of the Agency for Science, Technology and Research (A*STAR) announced two collaborations with ST Electronics (Info-Comm...</description><pubDate>Thu, 09 May 2013 12:00:00 AM GMT</pubDate></item><item><title>NeuroVive Pharmaceutical AB Starts Investor Relations Partnership With  </title><link>http://www.globenewswire.com/news-release/2013/05/08/545384/0/en/NeuroVive-starts-Investor-Relations-Partnership-with-Laika-Consulting.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;NeuroVive Pharmaceutical AB (publ) has initiated a collaboration within investorrelations communication with Laika Consulting, a company that specializes inhelping companies and other entities with their...</description><pubDate>Wed, 08 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;Zhejiang Huahai&lt;/b&gt; and Oncobiologics Inc. Sign Biosimilar Pact  </title><link>http://www.chinabiotoday.com/articles/20130508</link><description>by Richard Daverman, PhD&lt;/p&gt;&lt;p&gt;May 8, 2013 -- Zhejiang Huahai Pharma has joined with Oncobiologics, a New Jersey biologics startup, to form a partnership that will develop, manufacture and promote biosimilars. Huahai will have exclusive rights to make and market four Oncobiologics-developed biosimilars in China. The two companies will also sign a co-development and commercialization agreement to...</description><pubDate>Wed, 08 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Astellas Pharma Inc. and Drais Pharmaceuticals Join Forces With $15 Million to Launch Virtual Co.  </title><link>http://www.biospace.com/news_story.aspx?StoryID=295563&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;&lt;div id"releaseBody"&gt;&lt;p&gt;TOKYO and BRIDGEWATER, NJ--(Marketwired - May       07, 2013) -   Astellas Pharma Inc. (Tokyo: 4503) ("Astellas") and Drais Pharmaceuticals, Inc. ("Drais") today announced that they...</description><pubDate>Tue, 07 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Aesica Partners With the University of Nottingham to Develop Novel Amide Chemical Synthesis Technique  </title><link>http://www.biospace.com/news_story.aspx?StoryID=295510&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Newcastle, 7 May 2013: Aesica, the global contract manufacturing organisation (CMO), announces a partnership with the University of Nottingham for the commercial development of alternative methods in amide bond...</description><pubDate>Tue, 07 May 2013 12:00:00 AM GMT</pubDate></item><item><title>Recipharm AB and Join Forces to Promote Novel Drug Delivery Technology  </title><link>http://www.biospace.com/news_story.aspx?StoryID=295513&amp;full=1</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;7 May 2013 -- Recipharm Pharmaceutical Development AB and Synthonics, Inc. announce today the formation of a Joint Promotion Agreement. The contract, the first of its kind to be entered into between the two...</description><pubDate>Tue, 07 May 2013 12:00:00 AM GMT</pubDate></item><item><title>DBV Technologies and Mount Sinai Hospital Enter Into a Research Collaboration Agreement  </title><link>http://www.biospace.com/news_story.aspx?StoryID=295664&amp;full=1</link><description>&lt;div id"releaseBody"&gt;&lt;p&gt;BAGNEUX, FRANCE--(Marketwired - May       07, 2013) -   DBV Technologies (EURONEXT PARIS: DBV) (ISIN: FR0010417345), creator of Viaskin&amp;#174;, a new standard in the treatment of allergies, announced today a partnership with the Jaffe Food Allergy Institute at the Icahn School of Medicine at Mount Sinai (New York) for research related to the mechanism by which epicutaneous immunotherapy...</description><pubDate>Tue, 07 May 2013 12:00:00 AM GMT</pubDate></item><item><title>&lt;b&gt;PledPharma&lt;/b&gt; Appoints Advisor for the Commercialization of PledOx&amp;#0174;  </title><link>http://www.globenewswire.com/news-release/2013/05/06/544426/0/en/PledPharma-appoints-advisor-for-the-commercialization-of-PledOx.html</link><description>Staying up-to-date has never been simpler.  Sign up for the &lt;a href"http://www.biospace.com/enewsletter.aspx?typeseo-article&amp;sourcenews-signup"&gt;free GenePool newsletter&lt;/a&gt; today!&lt;br&gt;&lt;br&gt;Stockholm, 2013-05-06 08:30 CEST (GLOBE NEWSWIRE) -- PledPharma is looking to license PledOx to a major pharmaceutical company with a proven commitment to oncology.  The deal structure is expected to include...</description><pubDate>Mon, 06 May 2013 12:00:00 AM GMT</pubDate></item></channel></rss>